Female-Founded

Developed by a PhD Pharmacist

Made in Vancouver

Thoughtfully developed in Canada.

Advanced LNP3 Technology

Precision delivery designed for skin support.

Science-Driven Formulas

Developed with purpose, not trends.

Patented nano-dermal delivery

Where Clinical Delivery Meets Visible Skin Renewal.

novoLUX™ is powered by LNP3, a patented triple-layer lipid nanoparticle technology designed to deliver bioactives such as peptides, exosomes, and PDRN in a stable form.

Its nanoemulgel system supports sustained release for up to 24 hours while forming an invisible semi-occlusive film that helps hydrate the skin, support renewal, and reduce the look of irritation for smoother, healthier-looking, more radiant skin.

24HR Delivery
Targeted Support
Enhanced Natural Skin Renewal 
Headshot of CNANO's founder Dr. Ellie Rahmani

Vancouver-based pharmaceutics scientist advancing next-generation skin and hair regeneration

Dr. Ellie Rahmani is a dermatology and pharmaceutics scientist specializing in lipid nanoparticle and peptide delivery for skin and hair regeneration. With a research foundation rooted at the University of British Columbia, her work has helped define key scientific parameters for delivering peptides and bioactive molecules into the skin.

As the founder of CNANO Pharmaceuticals, Dr. Rahmani brings together pharmaceutical science, advanced nano-delivery technology, and regenerative skincare innovation to develop high-performance topical formulations designed for stability, precision, and visible skin support.

Meet Our Founder